SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-21-082643
Filing Date
2021-06-17
Accepted
2021-06-17 16:35:32
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A tm2114556d8_s1a.htm S-1/A 84323
2 EXHIBIT 3.2 tm2114556d8_ex3-2.htm EX-3.2 34106
3 EXHIBIT 3.4 tm2114556d8_ex3-4.htm EX-3.4 129451
4 EXHIBIT 4.1 tm2114556d8_ex4-1.htm EX-4.1 11714
5 EXHIBIT 10.2 tm2114556d8_ex10-2.htm EX-10.2 269602
6 EXHIBIT 10.3 tm2114556d8_ex10-3.htm EX-10.3 42394
7 EXHIBIT 10.4 tm2114556d8_ex10-4.htm EX-10.4 18415
8 EXHIBIT 10.5 tm2114556d8_ex10-5.htm EX-10.5 148921
9 EXHIBIT 10.6 tm2114556d8_ex10-6.htm EX-10.6 90574
10 EXHIBIT 10.10 tm2114556d8_ex10-10.htm EX-10.10 17611
11 GRAPHIC tm2114556d8_ex4-1img001.jpg GRAPHIC 403438
12 GRAPHIC tm2114556d8_ex4-1img002.jpg GRAPHIC 561896
  Complete submission text file 0001104659-21-082643.txt   2178111
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-256949 | Film No.: 211025203
SIC: 2834 Pharmaceutical Preparations